Immune Regulation News 1.00, October 9, 2009. Click here if you are unable to see images in this e-mail.

TOP STORIES

Promising New Target Emerges for Autoimmune Diseases
Discovery that chemistry in zone between cells influences immune T-cell activity also has implications for cancer therapies. [University of Michigan Medical Center, Ann Arbor]

EasySep


SCIENCE NEWS

National Report Shines Light on Lupus 50-Year Treatment Drought
A national health care consulting firm issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years. [Lupus Foundation of America, Inc., Washington DC]

'Natural Killer' Cells Keep Immune System in Balance
Researchers from Brown University and McGill University have discovered that the natural killer, or NK cells, help prevent T cells from over-responding when a virus hits. [Brown University, Providence]

RoboSep



CURRENT PUBLICATIONS

Extracellular Redox Modulation by Regulatory T cells
Researchers demonstrate that the mechanism of redox remodeling during mouse T-cell activation involves secretion of glutathione by dendritic cells and its subsequent cleavage to cysteine. [Nat Chem Biol]

Activating Receptors Promote NK Cell Expansion for Maintenance, IL-10 Production, and CD8 T Cell Regulation During Viral Infection
Studies demonstrate a previously unappreciated critical role for activating receptors in keeping NK cells present during viral infection to regulate adaptive immune responses. [J Exp Med]

Intestinal Lamina Propria Dendritic Cell Subsets Have Different Origin and Functions
The intestinal immune system discriminates between tolerance toward the commensal microflora and robust responses to pathogens. Maintenance of this critical balance is attributed to mucosal dendritic cells (DCs) residing in organized lymphoid tissue and dispersed in the subepithelial lamina propria. [Immunity]

A Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-15 Fusokine Induces a Regulatory B Cell Population with Immune Suppressive Properties
Researchers show that ex vivo GIFT15 treatment of mouse splenocytes generates suppressive regulatory cells of B cell ontogeny (hereafter called GIFT15 Breg cells). [Nat Med]

Mast Cells Counteract Regulatory T-cell Suppression Through Interleukin-6 and OX40/OX40L Axis Toward Th17-Cell Differentiation
In vivo analysis of lymph nodes hosting T-cell priming in experimental autoimmune encephalomyelitis revealed activated MCs, Tregs, and Th17 cells displaying tight spatial interactions, further supporting the occurrence of an MC-mediated inhibition of Treg suppression in the establishment of Th17-mediated inflammatory responses. [Blood]

The Same Systemic Autoimmune Disease Provokes Arthritis and Endocarditis via Distinct Mechanisms
Scientists report the discovery of spontaneous endocarditis, in addition to their well-studied autoimmune arthritis, in K/BxN T cell receptor (TCR) transgenic mice. [PNAS]

Insulin Teaches a New Lesson in Tolerance
Study describes how a failure of central tolerance to insulin causes type 1 diabetes in a mouse strain resistant to spontaneous autoimmune diabetes. [EMBO J]

NegSelRosetteSep_645x110_v01




INDUSTRY NEWS

ZymoGenetics: Merck Serono Halts MS Study
Seattle biotechnology company ZymoGenetics Inc. said Monday that Merck Serono SA had decided to halt studies of ZymoGenetics' drug candidate atacicept for treatment of multiple sclerosis.

EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States
EMD Serono, announced today the submission of a New Drug Application to the FDA for Cladribine Tablets, EMD Serono's proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS).



POLICY NEWS


THE NATIONAL INSTITUTES OF HEALTH (United States)

NIH Grants $152 Million in Institutional Development Awards
The National Center for Research Resources (NCRR), announced today it will provide up to an estimated $152 million over the next five years to fund Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) in nine IDeA-eligible states.




EVENTS

Autumn Immunology Conference 2009
November 20-23, 2009
Chicago, IL, USA

2009 Australasian Society for Immunology Meeting
December 6-10, 2009
Gold Coast, Australia

9th International Conference on New Trends in Immunosuppression and Immunotherapy
February 4-7, 2010
Prague, Czech Republic

13th International Conference on Lymphocyte Activation and Immune Regulation: Inflammasome and Inflammation
February 5-7, 2010
Newport Beach, California, USA

Keystone Symposium: Tolerance and Autoimmunity
February 16-21, 2010
Taos, New Mexico, USA

World Immune Regulation Meeting-IV
March 29-April 01, 2010
Davos, Switzerland

IMMUNOLOGY 2010
May 7-11, 2010
Baltimore, Maryland, USA

14th International Congress of Immunology
August 22-27, 2010
Kobe, Japan


Have we missed an important article or publication in Immune Regulation News? Click here to submit!

 
forwardafriendicon